IL-17 Constrains Natural Killer Cell Activity by Restraining IL-15–driven Cell Maturation Via SOCS3

Xuefu Wang,Rui Sun,Xiaolei Hao,Zhe-Xiong Lian,Haiming Wei,Zhigang Tian

DOI: https://doi.org/10.1073/pnas.1904125116

2019-01-01

Abstract:Significance IL-17A promotes tumorigenesis, metastasis, and viral infection. However, the underlying mechanisms remain elusive. By using diverse gene-deficient mice, antibody depletion, and animal models, we show that IL-17A promotes tumorigenesis, metastasis, and viral infection by constraining NK cell antitumor and antiviral activity via inhibition of NK cell maturation. The ablation of IL-17A signaling increases terminally mature CD27−CD11b+ NK cells, whereas constitutive IL-17A signaling reduces terminally mature NK cells. IL-17A suppresses IL-15–induced phosphorylation of STAT5 via up-regulation of SOCS3 in NK cells, leading to inhibition of NK cell terminal maturation. Therefore, IL-17A acts as the checkpoint during NK cell terminal maturation, which suggests potential interventions to defend against tumors and infections. Increasing evidence demonstrates that IL-17A promotes tumorigenesis, metastasis, and viral infection. Natural killer (NK) cells are critical for defending against tumors and infections. However, the roles and mechanisms of IL-17A in regulating NK cell activity remain elusive. Herein, our study demonstrated that IL-17A constrained NK cell antitumor and antiviral activity by restraining NK cell maturation. It was observed that the development and metastasis of tumors were suppressed in IL-17A–deficient mice in the NK cell-dependent manner. In addition, the antiviral activity of NK cells was also improved in IL-17A–deficient mice. Mechanistically, ablation of IL-17A signaling promoted generation of terminally mature CD27−CD11b+ NK cells, whereas constitutive IL-17A signaling reduced terminally mature NK cells. Parabiosis or mixed bone marrow chimeras from Il17a−/−and wild-type (WT) mice could inhibit excessive generation of terminally mature NK cells induced by IL-17A deficiency. Furthermore, IL-17A desensitized NK cell responses to IL-15 and suppressed IL-15–induced phosphorylation of signal transducer and activator of transcription 5 (STAT5) via up-regulation of SOCS3, leading to down-regulation of Blimp-1. Therefore, IL-17A acts as the checkpoint during NK cell terminal maturation, which highlights potential interventions to defend against tumors and viral infections.